Canntab Therapeutics Limited, the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased
Read MoreRecently, on 22 May 2019, through the judgment of RE 657.718 / MG, the Federal Supreme Court ruled that the
Read MoreWednesday, August 14, 2019 Boehringer Ingelheim has collaborated with The University of Texas MD Anderson Cancer Center to create a
Read MoreTuesday, August 13, 2019 Bioprinting company CELLINK has been granted a patent from the European Patent Office for a new
Read MoreTuesday, August 13, 2019 Catasys, Inc., a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A
Read More